Asthma control and steroid doses 5 years after early or delayed introduction of inhaled corticosteroids in asthma: A real-life study

Respiratory Medicine

Volumn 98, Issue 3, 2004, Pages 254-262

  Selroos, Olof ^a,b   Lofroos A B ^a   Pietinalho, A ^a   Riska, H ^a  

^a Department of Respiratory Medicine   (Finland)

^b NONE   (Sweden)

Author keywords

Asthma; Budesonide; Delayed treatment; Early treatment; Treatment goals; Turbuhaler

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CATARACT; CONTROLLED STUDY; DISEASE CONTROL; DISEASE DURATION; DISEASE EXACERBATION; DOSE RESPONSE; DRUG RESPONSE; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; FRACTURE; HUMAN; INHALER; INTERMETHOD COMPARISON; LUNG FUNCTION; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESPIRATORY FUNCTION; SYMPTOM; TREATMENT OUTCOME;

EID: 10744229116     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2003.10.007     Document Type: Article

References (29)

1. US National Heart, Lung & Blood Institute and World Health Organisation. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report, Washington, DC, NIH Publication No. 02-3659, 2002.
2. Asthma programme in Finland 1994-2004. Clin Exp Allergy 1996;26(Suppl 1):1-24.
3. 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991;325:388-92.
4. Haahtela T, Jrvinen M, Kava T, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;331:700-5.
5. Selroos O, Pietinalho A, Lfroos A-B, Riska H. Effect of early vs late intervention with inhaled corticosteroids in asthma. Chest 1995;108:1228-34.
6. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994;88:373-81.
7. Selroos O, Lfroos A-B, Niemist M, Pietinalho A, Backman R, Riska H. Early introduction with inhaled steroids in asthma results in achievement of treatment goals. Am J Respir Crit Care Med 1999;159:A627.
8. Greening AP, Ind PW, Northfield M, Shaw G. Treatment of adult asthmatic patients symptomatic on low dose inhaled corticosteroids: a comparison of the addition of salmeterol to existing inhaled corticosteroid therapy, with increasing the dose of inhaled corticosteroid. Lancet 1994;344: 219-24.
9. Pauwels RA, Lfdahl C-G, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997;337:1405-11.
10. Selroos O, Backman R, Forsn K-O, et al. Clinical efficacy of budesonide Turbuhaler compared with that of beclomethasone dipropionate pMDI with volumatic spacer. A 2-year randomized study in 102 asthma patients. Allergy 1994; 49:833-6.
11. Miyamoto T, Takahashi T, Nakajima S, et al. Efficacy of budesonide Turbuhaler compared with that of beclomethasone dipropionate pMDI in Japanese patients with moderately persistent asthma. Respirology 2001;6:27-35.
12. Agertoft L, Pedersen S. A randomized double-blind dose reduction study to compare minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. J Allergy Clin Immunol 1997;99:773-80.
13. Kuna P. A randomized, double-blind, double-dummy, parallel-group, multicenter, dose-reduction trial of the minimal effective doses of budesonide and fluticasone dry-powder inhalers in adults with mild to moderate asthma. Clin Ther 2003;25:2182-97.
14. SAS/STAT software: changes and enhancements through release 6.12. Cary NC: SAS Institue, 1997.
15. Adams RJ, Fuhlbrigge A, Finkelstein JA, et al. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma. Pediatrics 2001;107:706-11.
16. Suissa S, Ernst P, Beayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000;343:332-6.
17. Pauwels RA, Pedersen S, Busse WW, et al. Early intervention with budesonide in mild persistent asthma - the START study. Lancet 2003;361:1071-6.
18. O'Byrne PM, Barnes PJ, Rodriquez-Rosin R, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma. The OPTIMA randomized trial. Am J Respir Crit Care Med 2001;164:1392-7.
19. Turpeinen M. Helsinki early intervention childhood asthma study (HEICA). Inhaled budesonide halved the number of asthma exacerbations compared with inhaled disodium cromoglycate. Eur Respir J 2000;16(Suppl 16):311s.
20. Osterman K, Carlholm M, Ekelund J, et al. Effect of 1 year daily treatment with 100 μg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthma. Eur Respir J 1997;10: 2210-5.
21. Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA. Asthma programme in Finland: a community problem needs community solutions. Thorax 2001;56:806-14.
22. Selroos O, Backman R, Forsn K-O, et al. Local side-effects during 4-year treatment with inhaled corticosteroids - a comparison between pressurized metered-dose inhalers and Turbuhaler. Allergy 1994;49:888-90.
23. Johansson S-, Andersson K-E, Brattsand R, Gruvstad E, Hedner P. Topical and systemic glucocorticosteroid potencies of budesonide and beclomethasone dipropionate in man. Eur J Clin Pharmacol 1982;22:523-9.
24. Brambilla C, Lacronique J, Wallaert FA, Godard P, Duroux P. A 3-month comparative dose-reduction study with inhaled beclomethasone dipropionate and budesonide in the management of moderate to severe adult asthma. Drug Invest 1994;8:49-56.
25. van der Molen T, Kerstjens HAM. Starting inhaled corticosteroids in asthma: when, how high, and how long. Eur Respir J 2000;1:3-4.
26. Busse WW, Chervinsky P, Condemi J, et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 1998;101:457-63.
27. van der Molen T, Meyboom-de Jong B, Mulder HH, Postma DS. Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment. Am J Respir Crit Care Med 1998;158:121-5.
28. Tukiainen H, Taivainen A, Majander R, et al. Comparison of high and low dose of the inhaled steroid, budesonide, as an initial treatment in newly detected asthma. Respir Med 2000;94:678-83.
29. Selroos O, Lfroos A-B, Niemist M. A double-blind, randomized, dose-response study with budesonide in asthma patients with short or long duration of symptoms. Am J Respir Crit Care Med 1999;159:A627.